Albumin-covered lipid nanocapsules exhibit enhanced uptake performance by breast-tumor cells.


Liquid lipid nanocapsules (LLN) represent a promising new generation of drug-delivery systems. They can carry hydrophobic drugs in their oily core, but the composition and structure of the surrounding protective shell determine their capacity to survive in the circulatory system and to achieve their goal: penetrate tumor cells. Here, we present a study of… (More)
DOI: 10.1016/j.colsurfb.2018.02.024


  • Presentations referencing similar topics